2min chapter

Diabetes Core Update cover image

Diabetes Core Update – June 2023

Diabetes Core Update

CHAPTER

The Effects of the PCSK9 Inhibitor on LDL Levels

The results were positive. We knew that a couple of months ago. The relative risk reduction in the PCSK9 inhibitor for the primary outcome was 15%. And this theoretically was in a statin intolerant population. So these are truly impressive results because it's a group of people who, and Jamie, I've heard you lecture on this topic, there's around 10% of our patients who don't take statins because they can't tolerate them. They have a higher incidence of bad outcomes of MI.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode